The Number of People With Dementia is Expected to Double by 2050

The number of maladies as a result of COVID jabs continues to skyrocket at a pace so fast, Corporate Media and U.S. government agencies (think CDC, FDA, NIH) are having considerable difficulties spinning their lies. For those who may survive the bioweapon “vaccines,” more health troubles likely remain. Dementia is already being experienced, especially by those who took the boosters.

Photo by Mark Youso on

Dementia is the loss of cognitive functioning, which includes things like the ability to think, remember and reason, to the point where it interferes with a person’s daily life, according to the National Institute on Aging.

Types of dementia include Alzheimer’s disease, Lewy body dementia, vascular dementia, and Parkinson’s disease.

There’s an urgent need for safe and affordable interventions to protect people’s cognition against decline, especially older adults, says co-lead author Laura D. Baker, PhD, professor of gerontology and geriatric medicine at Wake Forest University School of Medicine in Winston Salem, North Carolina.

Recent research suggests that the actual incidence of dementia cases around the globe will continue to climb as a result of those who survive the jabs and as people living longer, along with risk factors that include smoking, obesity and high blood sugar. A study published in January 2022 in The Lancet projected that the number of adults living with some form of dementia in the United States will double by 2050, rising from 5.2 million people to 10.5 million.

Researchers ‘Shocked’ by Findings

While it is far too early to tell how jabs play into this, one notable trial was conducted in collaboration with Brigham and Women’s Hospital as part of the COSMOS trial (Cocoa Supplement and Multivitamin Outcomes Study), a study designed to examine the potential benefits in preventing heart disease, cancer, stroke, and other health outcomes.

Researchers randomized 21,442 men and women from across the United States. Those included in the trial were all over 65 years of age (the average age was 73), 60 percent women, and 89 percent white.

Participants were placed into one of four groups in a “two-by-two” trial; in one study, people who took a daily cocoa extract (containing 500 milligrams per day of flavanols) were compared with those who took a placebo tablet, and in the second trial, people who took an over-the-counter daily multivitamin-mineral supplement were compared with a group taking a placebo supplement.

A cognitive test was performed over the phone to establish a baseline, and then repeated annually over the three-year follow-up. The test included a word list and story recall, verbal fluency, digit ordering, and other tools to measure memory as well as the speed and accuracy of cognitive processing.

Photo by Kindel Media on

The researchers went into the trial expecting the group taking the cocoa extract to reap the most cognitive benefits. That’s because cocoa extract is rich in compounds called flavanols (dark chocolate contains flavonoids) and past research suggests that these compounds may positively impact cognition, according to Baker. “There’s also preliminary data that shows that cocoa flavanols were very beneficial for cardiovascular health,” she says.

It’s thought that flavonoids work by potentially improving blood flow to the brain and reducing inflammation. “Anytime you can improve cardiovascular health, you improve cognition — they are intimately tied,” says Baker.

However, at the end of the study, the findings showed that those who took the cocoa extract containing flavanols didn’t show any cognitive improvements compared with the placebo group.

“That was not what we were expecting — we were kind of shocked that there was no benefit,” says Baker.

Just as surprising, investigators found that taking a daily multivitamin-mineral supplement resulted in statistically significant cognitive improvement. They estimated that three years of taking a multivitamin roughly translated to a 60 percent slowing of cognitive decline — about 1.8 years.

Several Vitamins and Minerals Are Needed to Support Brain Function

This is the first evidence of cognitive benefit in a large longer-term study of multivitamin supplementation in older adults, a finding that was also somewhat unexpected, says Baker. Previous studies that looked at cognition and multivitamins have showed mixed results, she adds. 

Several micronutrients and minerals are needed to support normal body and brain function, and deficiencies in older adults may increase the risk for cognitive decline and dementia, and that’s where the multivitamin may provide some level of protection, says Baker.

Is there a specific vitamin or mineral that is especially beneficial for the brain? That’s not known, says Baker. If further research confirms that vitamins do indeed help with cognition, it may be that it’s not one specific vitamin or mineral but rather a synergistic effect of two or more components of the multivitamin that are providing the benefits, she says. “We still have work to do to better understand why the multivitamin might benefit cognition in older adults.”

The cognitive benefits in the group taking a daily vitamin were relatively more pronounced in participants with significant cardiovascular disease, a factor that the authors considered notable because these individuals are already at increased risk for cognitive impairment and decline.

Photo by Magda Ehlers on

Good Nutrition Is Essential for Brain Health

While there is still more to be learned about vitamin supplements and brain health, we do know that even slight declines in our vitamin and micronutrient deficiencies can have consequences for the brain, says Baker. “Unfortunately, in the U.S., we tend to eat foods that are rich in saturated fats and a lot of carbohydrates and we often don’t eat enough of foods that are high in nutrient value,” she says.



  1. With the ever increasing population, all rates go up every year. We humans breed like rabbits. Plus, the ever increasing of fast food and processed food with unknown chemicals in them – the size of the vaccination dose is a drop in the bucket.

    Liked by 1 person

        • Dr. David Weaver, keynote lecturer at annual Alzheimer’s Awareness Conference; Chris Bunks, as CEO provided latest research to Lexaria Biotech shareholders; research from the Care Policy and Evaluation Centre (CPEC) at the London School of Economics and Political Science (LSE) and Newcastle University;  Dr. Richard Harvey, director of research for the Alzheimer’s Society, Ben Greener, neurology analyst at analysts Datamonitor,National Institutes of Health researcher Andrew B. Singleton, PhD; Lancet Psychiatry journal.. My wife, a retired RN (specializes in immunology & is constantly in touch with experts in the field. We don’t get our info from mainstream sources which could be tainted. We refer mainly with subject matter experts in almost all of our articles. She has doctors, nurses, researchers, scientists that she relies on. I have law enforcement, government, medical, entertainment, legal and business experts as sources. Over many years we have garnered reliable (often times confidential) sources. And you, how did you determine your hypnosis?

          Liked by 2 people

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.